ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
3367	National Human Genome Research Institute	Html	null	Online Education Kit: Understanding the Human Genome Project	Includes a history and descriptions of the Human Genome Project including a timeline, how to sequence a genome, bioinformatics, genes variation and human history and more.			CLICK HERE
15538	National Institute of Allergy and Infectious Diseases	Html	en	NIAID's Programs on Asthma in the Inner City	Recognizing that asthma severity in inner-city children is disproportionately high, NIAID has sponsored research to reduce the public health burden that asthma presents in inner-city populations. Beginning in 1991, NIAID has supported three consecutive inner-city asthma research programs, which have been successful in reducing asthma severity in children.	inner-city populations 0.579525 Morgan WJ 0.496915 cockroach allergen 0.471241 inner-city children. 0.516784 asthma severity 0.746089 inner-city adolescents 0.569622 environmental intervention study 0.506189 clinical trials 0.457073 Infectious Diseases networks 0.482159 asthma exacerbations 0.604543 asthma attacks 0.618501 Gergen PJ 0.506952 City Anti-IgE Therapy 0.499916 asthma 0.9777 Pongracic JA 0.498 Szefler SJ 0.504609 Busse WW. Management 0.518055 Asthma Control Evaluation 0.678562 asthma treatment guidelines 0.681693 Gruchalla RS 0.496061 Allergy Clin Immunol. 0.483813 Busse WW. 0.518705 asthma management 0.634222 omalizumab 0.464849 severe allergic asthma 0.661933	asthma morbidity 0.639521 ICAC investigators 0.510592 CA. Randomized trial 0.488723 guidelines-based asthma therapy 0.667931 asthma presents 0.660928 nitric oxide level 0.504737 William Busse 0.501488 follow-on clinical trial 0.490114 asthma treatment 0.724256 public health burden 0.502806 exhaled nitric oxide 0.589522 at-risk children 0.467554 inner city 0.546793 Liu AH 0.496615 Teach SJ 0.501285 clinical guidelines 0.486081 principal investigators 0.485986 Asthma counselors 0.64051 ICAC program 0.497263 inner-city asthma research 0.793594 basic research sites 0.543997 year-long study 0.459719 inner-city children 0.771731 asthma symptoms 0.641572	CLICK HERE
15541	National Institute of Allergy and Infectious Diseases	Html	en	Sample Applications and Summary Statements -- NIAID Research Funding	Sample Applications and Summary Statements and a list of all samples and examples that are part of the grant application from NIAID and NIH -- NIAID Research Funding	application format 0.907608 grantee organization 0.765229 funding opportunity 0.767168 Dr. Andrew Hemmert 0.871038 new research projects 0.933476 feasibility studies 0.741985 R33 phase 0.759832 ethnic groups 0.738984 sound examples 0.760636 sample applications 0.791811 widely anticipated resource 0.905833 research community 0.804124 major recipients 0.749258 independent research career 0.905416 small-scale research projects 0.918897 predoctoral students 0.755344 good grantsmanship 0.776715 limited resources 0.753355 Research Enhancement Award 0.912673 grant renewal 0.750527 model systems 0.747297 R21 phase 0.802738 original grant application. 0.876558 exceptional applications 0.795607	two-phased award 0.744601 latest application format 0.89336 summary statements 0.774822 possible transition 0.745699 new samples 0.775894 milestone-driven exploratory 0.747537 new investigators 0.919996 domestic small businesses 0.862103 research training 0.778846 NIH example forms 0.929049 Dr. Hemmert 0.748615 nonprofit educational purposes 0.880734 short period 0.753535 Small Business Programs 0.860069 R21 funds novel 0.915071 research environment 0.789167 NIH support 0.763875 disadvantaged backgrounds 0.737728 *Dr. Mark Poritz 0.868098 biomedical research 0.780582 Dr. Poritz 0.748763 educational institutions 0.749988 program supports 0.759468 scientific ideas 0.747402	CLICK HERE
15544	National Institute of Allergy and Infectious Diseases	Html	en	Global Research in Cambodia	NIAID-funded research in Cambodia focuses on HIV/AIDS, tuberculosis, malaria, and avian influenza.	reports 0.235345 avian influenza 0.914596 Cambodia 0.841837 Khmer population 0.414517 infectious diseases 0.430183 Cambodian center 0.395105 steady growth 0.450129 malaria-affected areas 0.409225 malaria research laboratory 0.84082 malaria drug resistance 0.823015 malaria treatment 0.708295 problem 0.265615 different settings 0.392781 micronutrients 0.250825 majority 0.237584 clinical study 0.394312 National Center 0.391275 NIAID-funded research 0.424039 Parasitology 0.239748 World Health Organization 0.596215 avian influenza infection 0.641213 Intramural Research 0.416096 clinical research studies 0.584188 NIAID DIR 0.565328	dengue fever 0.447449 malaria episode 0.708655 substandard antimalarial drugs 0.668757 future collaborative research 0.563796 natural protection 0.406267 multidrug resistance 0.442439 risk behavior 0.399297 CNM 0.308846 Phnom Penh 0.425895 Malaria Control 0.663084 healthcare 0.237926 research partnership 0.40453 counterfeit 0.247239 particular group 0.407261 HIV/AIDS 0.343462 Vector Research 0.402611 co-infection 0.260805 NIAID Division 0.518719 people 0.265199 malaria deaths 0.695752 Plasmodium falciparum parasite 0.624047 antiretroviral therapy 0.419276 treatment response 0.400285 education systems 0.432324	CLICK HERE
15545	National Institute of Allergy and Infectious Diseases	Html	en	Methicillin-Resistant Staphylococcus aureus MRSA, Antimicrobial Resistance	NIAID conducts and supports research on methicillin-resistant Staphylococcus aureus, MRSA--drug-, or antimicrobial-, resistant bacteria that has become a serious public health concern.	Allergy 0.341577 Require 0.335974 Experts 0.328592 Research > Antimicrobial 0.486656 Pathway 0.34693 methicillin-resistant staphylococcus aureus 0.971182 controllable nuisance 0.508668 HIV Vaccine 0.518468 NIAID-Supported Institutions 0.464562 Research > NIAID 0.500955 MRSA 0.488992 News 0.326356 new strains 0.473848	Universal Influenza Vaccine 0.682447 HIV/AIDS Pandemic Likely 0.665604 public health concern 0.611156 National Institute 0.496139 NIH 0.350088 allergic diseases 0.501528 severe infections 0.473944 Role 0.327169 Infectious Diseases 0.524019 decades 0.338877 hospital-acquired infection 0.507902 Durable End 0.489538	CLICK HERE
15550	National Institute of Allergy and Infectious Diseases	Html	en	Intramural NIAID Research Opportunities INRO, NIH	INRO is an NIAID 4-day exploratory program that connects minority science students with training opportunities in immunology and infectious diseases.	INRO email updates 0.738453 financially disadvantaged backgrounds 0.982393 multi-disciplinary research facility 0.838981 recent hurricanes 0.496559 medical students 0.522578 research training experience 0.829391 program 0.227182	NIAID 0.411192 biomedical research 0.532386 hardship 0.209827 hotel accommodations 0.500268 application process 0.466663 difficult time 0.488892 diverse research community 0.837556	CLICK HERE
15552	National Institute of Allergy and Infectious Diseases	Html	en	Dengue Fever, NIAID, NIH	NIAID health and research information on dengue fever	dengue animal models 0.637025 related dengue viruses 0.700576 New research findings 0.39085 point-of-care machine 0.349211 dengue infection 0.729539 economic burden 0.353666 dengue vaccines 0.665616 muscle pain 0.354058 rapid dengue diagnosis 0.618858 small molecule drugs 0.38263 Western hemisphere 0.353064 clinical trials 0.351867 live-attenuated dengue viruses 0.642326 dengue-endemic countries 0.348281 dengue research projects 0.662649 diagnostic tests 0.396946 specific diagnostic tests 0.387357 human trials 0.348533 community-based prevention programs 0.394083 vaccine approach 0.349325 recombinant version 0.351126 viral factors 0.354135 dengue fever 0.846342 laboratory-based international surveillance 0.396575 rapid diagnostic tests 0.391709	healthcare providers 0.353653 treatment strategies 0.350986 United States 0.35404 global health threat 0.393267 dengue shock syndrome 0.744003 NIAID researchers 0.395179 infected people 0.351147 different viral dengue 0.634725 public health 0.35259 NIAID research priorities 0.443797 dengue disease 0.600916 recombinant proteins 0.349944 Health experts 0.357315 severe forms 0.399676 dengue 0.999102 viral proteins 0.352028 MedlinePlus dengue site 0.654335 viral vectors 0.355429 basic research activities 0.394177 dengue hemorrhagic fever 0.763697 NIAID projects 0.394476 new treatment options 0.386411 effective vaccine 0.349229 infectious disease 0.367495	CLICK HERE
15553	National Institute of Allergy and Infectious Diseases	Html	en	Autoimmune Lymphoproliferative Syndrome (ALPS)	General and NIAID research information about Autoimmune lymphoproliferative syndrome (ALPS).	red blood cells 0.498965 Genetics Home Reference 0.386541 common type 0.27372 enlarged spleen 0.273296 treatment strategies 0.256376 clinical findings 0.247554 better understanding 0.262253 inflammatory bowel diseases 0.386467 primary immune deficiency 0.43025 normal cell lifecycle 0.380592 genetic defects 0.264434 low blood cell 0.387723 abnormal buildup 0.395762 low count 0.525489 common autoimmune diseases 0.498412 blood cells. 0.260493 research questions 0.258643 autoimmune lymphoproliferative syndrome 0.860748 systemic lupus erythematosus 0.388262 NIAID researchers 0.384049 white blood cells 0.708626 numerous autoimmune problems 0.563557 lymphoproliferative syndrome site 0.41581 related disorders 0.38884	major clinical symptoms 0.374436 NIAID PIDD site 0.506663 current management 0.256481 National Library 0.256237 increased risk 0.262725 PIDD research 0.257719 autoimmune diseases 0.588163 effective treatments 0.265251 risk factors 0.248383 white blood cell 0.447537 cell death 0.256903 genetic characteristics 0.264791 patient care 0.257891 rheumatoid arthritis 0.249292 rare genetic disorder 0.433441 ALPS 0.995498 NIAID focus 0.38608 FAS gene cause 0.410071 autoimmune destruction 0.357642 lymph nodes 0.291536 FAS gene 0.591557 genome sequencing 0.254615 debilitating symptoms 0.274164	CLICK HERE
15554	National Institute of Allergy and Infectious Diseases	Html	en	Biodefense Category A, B, C Pathogens	NIAID biodefense Category A, B, C pathogens	Additional Emerging Infectious 0.832106 Centers 0.421008 host defenses 0.530437 United States 0.52892 NIAID biodefense/EID mission 0.732951 highest priority 0.718109 Category C pathogens 0.679223 Biodefense Research 0.623199 U.S. Department 0.53081 complete scope 0.522633 Prevention 0.420958 conjunction 0.425199 Disease Control 0.527974 geographic range 0.544192 Emerging Infectious Diseases/Pathogens 0.964432 priority pathogens 0.731074 public health 0.526578 Notes 0.420393 pathogen threats 0.55739	national security 0.524884 HIV/AIDS 0.422564 Diseases/Pathogens category 0.607089 federal partners 0.531115 NIAID Emerging Infectious 0.962085 priority organisms/biological agents 0.689595 Category B pathogens 0.686236 Homeland Security 0.535344 intramural program management 0.634748 revision 0.425668 population 0.422041 NIAID Category 0.742626 biodefense effort 0.588256 highest risk 0.556143 pathogen priority list 0.734849 mass dissemination 0.523841 threat assessments 0.532316 Immunology studies 0.522128	CLICK HERE
15981	National Institute of Allergy and Infectious Diseases	Video	en	Influenza: Get the (Antigenic) Drift	Have you ever wondered why you need a flu vaccination each year? The National Institute of Allergy and Infectious Diseases explains the ever-changing nature of influenza viruses.	Action MOA Animation 0.579913 Shomu 0.416725 Allergy 0.416577 SwineFlu 0.416001 Daniel Levy 0.496516 flutube100 0.416238 Osmosis 0.416074 H1N1 Swine Flu 0.627108 Unpredictable Threat 0.498722 flu vaccination 0.597572 milos velja 0.493184 World Health Organization 0.57148 1918 Flu Pandemic 0.627835 flu virus mechanism 0.693678 reverse transcriptase 0.494547 Duration 0.949875 Virus Invades 0.512664 AMAZING DOCUMENTARY 0.485888 autoplay 0.453443 HIV life cycle 0.567135 Carolyn Bertozzi 0.598025 Infectious Diseases 0.507143 Influenza H1N1 Mechanism 0.7022 VIRUS EVOLUTION 0.501245 antigenic shift 0.607123	influenza 0.762967 720p 0.423131 iBioEducation 0.42898 Influenza animation 0.642901 Influenza Pandemics Occur 0.718554 Biology 0.416713 video 0.418444 Genetic Shift 0.503494 Berkeley/HHMI 0.429072 ever-changing nature 0.51424 views 0.737316 National Institute 0.509002 Fighting flu 0.555906 Influenza infection model 0.670194 Immune Response 0.487687 David Hager 0.509045 Scientific Animations 0.498803 DOCUMENTARY TUBE 0.482643 NIAID 0.456714 Influenza Virus Infection 0.688245 Flu Attack 0.564409 influenza viruses 0.646604 Nucleus Medical Media 0.585917 Million People 0.484786	CLICK HERE